Stuelpnagel John R: insider trades.
Stuelpnagel John R reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.4M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- STUELPNAGEL JOHN R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| 10x Genomics, Inc. (TXG) | Director | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | 10x Genomics, Inc. | S | 6,814 | $62.11 | 334,610 | Form 4 |
| 2026-09-03 | 10x Genomics, Inc. | S | 7,012 | $60.66 | 341,424 | Form 4 |
| 2026-09-03 | 10x Genomics, Inc. | S | 6,174 | $62.61 | 328,436 | Form 4 |
| 2026-08-11 | 10x Genomics, Inc. | S | 3,000 | $58.73 | 348,436 | Form 4 |
| 2026-08-11 | 10x Genomics, Inc. | S | 17,000 | $57.58 | 351,436 | Form 4 |
Questions
What stock did Stuelpnagel John R buy or sell?
Stuelpnagel John R reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.4M), across 1 company.
Is Stuelpnagel John R the same person as other filers with this name?
This page covers SEC CIK 1189140 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/stuelpnagel-john-r-1189140.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.